PEARL - A Phase 1 trial of PET-based adaptive radiotherapy in patients undergoing radical chemoradiotherapy for human papilloma virus (HPV)-positive oropharyngeal cancer - CONVERIS Research Information System by Thomson Reuters:

Go to Header Go to Navigation Go to Content Go to Footer

Title: PEARL - A Phase 1 trial of PET-based adaptive radiotherapy in patients undergoing radical chemoradiotherapy for human papilloma virus (HPV)-positive oropharyngeal cancer

Funder
Cancer Research Wales

Principal Investigator

Nixon, Lisette

Project Details

Net value award figure for Cardiff University: £178,571.00

Start date: 01/02/2018

End date: 31/08/2025

Our policy towards the use of cookies